MNCSX | VTSNX | MNCSX / VTSNX | |
Total Expense Ratio | 0.62 | 0.06 | 1,033% |
Annual Report Gross Expense Ratio | 1.00 | 0.06 | 1,667% |
Fund Existence | 4 years | 15 years | - |
Gain YTD | 28.981 | 21.893 | 132% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 5000000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 3.8B | 526B | 1% |
Annual Yield % from dividends | 4.15 | 2.73 | 152% |
Returns for 1 year | 19.58 | 16.27 | 120% |
Returns for 3 years | 65.83 | 47.45 | 139% |
Returns for 5 years | N/A | 40.95 | - |
Returns for 10 years | N/A | 70.17 | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
FBTDX | 126.01 | 2.56 | +2.07% |
Franklin Biotechnology Discovery C | |||
WGLSX | 13.31 | 0.17 | +1.29% |
Wasatch Long/Short Alpha Institutional | |||
TWQIX | 16.54 | -0.03 | -0.18% |
Transamerica Large Cap Value I | |||
OEICX | 96.12 | -0.30 | -0.31% |
JPMorgan Equity Index C | |||
NWAWX | 14.46 | -0.08 | -0.55% |
Nationwide GQG US Quality Eq Instl Ser |